VD
Vito G. D'Agostino
  • Group Leader, Department of Cellular, Computational and Integrative Biology, University of Trento, 2018-
Research fields
  • Cancer biology
Personal information

Education

Ph.D. in genetics and Biomolecular Sciences, Department of Genetics and Microbiology, University of Pavia, Italy, 2010

Publications

Selected publications:
• Notarangelo, M., Zucal, C., Modelska, A., Pesce, I., Scarduelli, G., Potrich, C., Lunelli, L., Pederzolli, C., Pavan, P., la Marca, G., Pasini, L., Ulivi, P., Beltran, H., Demichelis, F., Provenzani, A., Quattrone, A. and D'Agostino, V. G. (2019). Ultrasensitive detection of cancer biomarkers by nickel-based isolation of polydisperse extracellular vesicles from blood. EBioMedicine 43: 114-126.
• D'Agostino, V. G., Sighel, D., Zucal, C., Bonomo, I., Micaelli, M., Lolli, G., Provenzani, A., Quattrone, A. and Adami, V. (2019). Screening Approaches for Targeting Ribonucleoprotein Complexes: A New Dimension for Drug Discovery. SLAS Discov 24(3): 314-331.
• Tebaldi, T., Zuccotti, P., Peroni, D., Köhn, M., Gasperini, L., Potrich, V., Bonazza, V., Dudnakova, T., Rossi, A., Sanguinetti, G., Conti, L., Macchi, P., D'Agostino, V., Viero, G., Tollervey, D., Huttelmaier, S. and Quattrone, A. (2018). HuD Is a Neural Translation Enhancer Acting on mTORC1-Responsive Genes and Counteracted by the Y3 Small Non-coding RNA. Mol Cell 71(2): 256-270 e210.
• Dalle Vedove, A., Spiliotopoulos, D., D'Agostino, V. G., Marchand, J. R., Unzue, A., Nevado, C., Lolli, G. and Caflisch, A. (2018). Structural Analysis of Small-Molecule Binding to the BAZ2A and BAZ2B Bromodomains. ChemMedChem 13(14): 1479-1487.
• Manzoni, L., Zucal, C., Maio, D. D., D'Agostino, V. G., Thongon, N., Bonomo, I., Lal, P., Miceli, M., Baj, V., Brambilla, M., Cerofolini, L., Elezgarai, S., Biasini, E., Luchinat, C., Novellino, E., Fragai, M., Marinelli, L., Provenzani, A. and Seneci, P. (2018). Interfering with HuR-RNA Interaction: Design, Synthesis and Biological Characterization of Tanshinone Mimics as Novel, Effective HuR Inhibitors. J Med Chem 61(4): 1483-1498.
• Lal, P., Cerofolini, L., D'Agostino, V. G., Zucal, C., Fuccio, C., Bonomo, I., Dassi, E., Giuntini, S., Di Maio, D., Vishwakarma, V., Preet, R., Williams, S. N., Fairlamb, M. S., Munk, R., Lehrmann, E., Abdelmohsen, K., Elezgarai, S. R., Luchinat, C., Novellino, E., Quattrone, A., Biasini, E., Manzoni, L., Gorospe, M., Dixon, D. A., Seneci, P., Marinelli, L., Fragai, M. and Provenzani, A. (2017). Regulation of HuR structure and function by dihydrotanshinone-I. Nucleic Acids Res 45(16): 9514-9527.
• Mandrioli, J., Crippa, V., Cereda, C., Bonetto, V., Zucchi, E., Gessani, A., Ceroni, M., Chio, A., D'Amico, R., Monsurro, M. R., Riva, N., Sabatelli, M., Silani, V., Simone, I. L., Soraru, G., Provenzani, A., D'Agostino, V. G., Carra, S. and Poletti, A. (2019). Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS). BMJ Open 9(5): e028486.
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.